形式 : |
雑誌 |
ウェブリンク : |
http://www.currenttherapeuticres.com/article/S0011-393X(15)00016-8/abstract |
|
研究チーム : |
San Francisco - Theravance Biopharma |
著者 : |
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
表題 : |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. |
引用文献 : |
Current Ther Res ; 77: 105-110. 2015 |
|
エビデンスレベル : |
|
物理的安定性 : |
|
化学的安定性 : |
|
その他の方法 : |
|
注釈 : |
|
薬剤一覧
Telavancin hydrochloride
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|